FundingWatcher
Home / Startups / Top health care startups / Health care startups in Jiangsu, China

Health care startups in Jiangsu, China

Updated 16 Nov 2026

Reset
Health care startups in Jiangsu, China
One-time CSV
  • 421 funded companies, 271 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care~jiangsu-china.csv421 rows × 18 columns
CompanyCityLast roundAmountDate
Weikaier Pharmaceutical TechnologyNanjingSeries C$29.6M2026-06-02
Kossel MedicalSuzhouSeries C$59.5M2026-09-01
D3 BioWuxi ShiSeries B$108.0M2025-12-09
HemaCellSuzhouSeries B$14.8M2026-06-02
Hope MedicineNanjingSeries B$18.5M2024-09-27
iCamumoSuzhouSeries A$14.4M2026-03-09
AccuPulseSuzhouSeries B$14.5M2026-03-13
Yuce BiotechnologySuzhouSeries B$7.4M2026-08-31

8 rows of the CSV in 5 of its 18 columns.

421
Startups
$6.1B
Total raised
79
Funded in the last 12 months
$881.4M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

23 of 421
23 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Kossel Medical Kossel Medical develops and manufactures vascular interventional devices and clinical system solutions. Health care Suzhou Series C $59.5M 2026-09-01 $103.0M Fortune Venture Capital, Suzhou International Development Venture Capital, Ming Bioventures +1 501 to 1,000 2013
Yuce Biotechnology Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. Biotech Suzhou Series B $7.4M 2026-08-31 $22.4M Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 101 to 250 2019
Haimai Medical Haimai Medical develops tissue engineering and regenerative medicine technologies. Health care Suzhou Series A $14.3M 2026-06-12 $14.3M IDG Capital, Shanghai Biomedical Industrial Equity Investment Fund, Tahoe Venture +1 51 to 100 2021
Weikaier Pharmaceutical Technology Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. Biotech Nanjing Series C $29.6M 2026-06-02 $120.4M SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 501 to 1,000 2010
HemaCell HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. Biotech Suzhou Series B $14.8M 2026-06-02 $62.0M Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation 1 to 10 2021
AccuPulse AccuPulse develops pulsed electric field ablation generators and catheters. Health care Suzhou Series B $14.5M 2026-03-13 $72.5M BioVenture, Shanghai Biomedical Industrial Equity Investment Fund, Med-Fine Capital +1 11 to 50 2020
iCamumo iCamumo develops off-the-shelf, general-purpose cell therapies using iPSCs. Biotech Suzhou Series A $14.4M 2026-03-09 $75.2M Delian Capital, West Lake Science and Technology Direct Investment Fund, Zhiyi Investment 51 to 100 2021
Tingsheng Technology Tingsheng Technology develops intracardiac ultrasound (ICE) products. Health care Nanjing Series B $13.9M 2026-03-05 $52.8M Qiming Venture Partners, Taiyu Investment, Tao Capital +2 2017
Micro-Ray Technology Micro-Ray Technology supplies X-ray tubes and component solutions for medical imaging equipment such as CT machines. Biotech Suzhou Seed $14.4M 2026-01-23 $14.4M Suzhou Xiangcheng Financial Holding Group 11 to 50 2021
Junji Gene Junji Gene provides intelligent gene synthesis labs and localizes raw materials for diagnostic kits. Artificial intelligence Suzhou Series A $14.2M 2025-12-15 $14.2M Dongfang Jiafu 51 to 100 2021
D3 Bio D3 Bio develops and registers medicines as a biotechnology company. Biotech Wuxi Shi Series B $108.0M 2025-12-09 $370.0M Matrix Partners China, Boyu Capital, Medicxi 1 to 10 2020
Kunshi Biotechnology Kunshi Biotechnology develops drugs with an emphasis on solid tumor cells. Biotech Suzhou Series A $7.0M 2025-11-20 $7.0M Deshi Capital 51 to 100 2021
IMPACT Therapeutics IMPACT Therapeutics develops similar drugs to treat cancer. Biotech Nanjing Series D $34.6M 2024-11-15 BioVenture, Lilly Asia Ventures, Decheng Capital +2 51 to 100 2009
Hope Medicine Hope Medicine develops science-driven biopharmaceutical treatments in clinical development. Health care Nanjing Series B $18.5M 2024-09-27 $102.6M Qiming Venture Partners, Sinovation Ventures, Trustbridge Partners +2 1 to 10 2018
DK MedTech DK MedTech manufactures vascular interventional medical device products. Health care Suzhou Series E $24.5M 2024-06-21 $36.2M Qiming Venture Partners, Legend Capital, Oriza Seed Capital (Oriza Yuandian) +1 251 to 500 2015
Yidao Biotechnology Yidao Biotechnology researches and develops vaccines and biomedical products. Biotech Suzhou Series D $25.2M 2024-05-09 Qiming Venture Partners, Northern Light Venture Capital 2017
Tuge Medical Technology Tuge Medical Technology develops and industrializes 4K endoscopic imaging equipment and digital operating rooms. Health care Nanjing Series B $27.7M 2024-04-10 $27.7M LongRiver Investments 101 to 250 2018
CureGenetics CureGenetics develops medicines and molecular diagnostics for cancers and genetic diseases. Biotech Suzhou Series B $9.0M 2024-03-28 Qiming Venture Partners, Oriza Holdings, Qingsong Fund +1 51 to 100 2016
Atom Bioscience & Pharmaceutical Atom Bioscience is a clinical-stage biotechnology company. Biotech Suzhou Series D $82.1M 2023-10-16 Fortune Venture Capital, Oriza Holdings, Kaitai Capital +1 11 to 50 2012
Zenshine Pharma Zenshine Pharma develops small molecule drugs for cancer and autoimmune diseases. Biotech Nanjing Series C $13.7M 2023-10-13 $28.7M Matrix Partners China, Cybernaut Venture Capital, Kunlun Capital +2 11 to 50 2018
Onechip Bioelectronics Onechip Bioelectronics develops biosensor chips and nanomaterials. Biotech Zhangjiagang Series B $13.7M 2023-09-28 Matrix Partners China, Qiming Venture Partners, Xiamen C&D Emerging Industry Equity Investment +1 11 to 50 2014
Chamlion Chamlion provides end-to-end digital dentistry solutions based on 3D printing. Hardware Nanjing Series B $34.3M 2023-04-19 Vertex Ventures China, Zhencheng Capital, 3H Health Investment +1 501 to 1,000 2017
Weiyun AI Weiyun AI combines medical health and artificial intelligence to manufacture clinical dental products. Artificial intelligence Nanjing Series B $15.2M 2021-03-30 AlphaX Partners 1 to 10 2018

Table 1. Health care startups in Jiangsu, China: the 23 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 421.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 D3 Bio D3 Bio develops and registers medicines as a biotechnology company. Biotech Wuxi Shi Series B $108.0M 2025-12-09 $370.0M Matrix Partners China, Boyu Capital, Medicxi 1 to 10 2020
2 Kossel Medical Kossel Medical develops and manufactures vascular interventional devices and clinical system solutions. Health care Suzhou Series C $59.5M 2026-09-01 $103.0M Fortune Venture Capital, Suzhou International Development Venture Capital, Ming Bioventures +1 501 to 1,000 2013
3 Weikaier Pharmaceutical Technology Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. Biotech Nanjing Series C $29.6M 2026-06-02 $120.4M SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 501 to 1,000 2010
4 HemaCell HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. Biotech Suzhou Series B $14.8M 2026-06-02 $62.0M Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation 1 to 10 2021
5 AccuPulse AccuPulse develops pulsed electric field ablation generators and catheters. Health care Suzhou Series B $14.5M 2026-03-13 $72.5M BioVenture, Shanghai Biomedical Industrial Equity Investment Fund, Med-Fine Capital +1 11 to 50 2020
6 iCamumo iCamumo develops off-the-shelf, general-purpose cell therapies using iPSCs. Biotech Suzhou Series A $14.4M 2026-03-09 $75.2M Delian Capital, West Lake Science and Technology Direct Investment Fund, Zhiyi Investment 51 to 100 2021
7 Micro-Ray Technology Micro-Ray Technology supplies X-ray tubes and component solutions for medical imaging equipment such as CT machines. Biotech Suzhou Seed $14.4M 2026-01-23 $14.4M Suzhou Xiangcheng Financial Holding Group 11 to 50 2021
8 Haimai Medical Haimai Medical develops tissue engineering and regenerative medicine technologies. Health care Suzhou Series A $14.3M 2026-06-12 $14.3M IDG Capital, Shanghai Biomedical Industrial Equity Investment Fund, Tahoe Venture +1 51 to 100 2021
9 Junji Gene Junji Gene provides intelligent gene synthesis labs and localizes raw materials for diagnostic kits. Artificial intelligence Suzhou Series A $14.2M 2025-12-15 $14.2M Dongfang Jiafu 51 to 100 2021
10 Tingsheng Technology Tingsheng Technology develops intracardiac ultrasound (ICE) products. Health care Nanjing Series B $13.9M 2026-03-05 $52.8M Qiming Venture Partners, Taiyu Investment, Tao Capital +2 2017

Table 2. Health care startups in Jiangsu, China: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Qiming Venture Partners Venture capital firm Shanghai, China 8 2% 1 Tingsheng Technology
2 Oriza Holdings Venture capital firm Suzhou, China 5 1%
3 BioVenture Venture capital firm Suzhou, China 4 1% 1 AccuPulse
4 Matrix Partners China Venture capital firm Beijing, China 3 1% 1 D3 Bio
5 Wuxi Capital Angel group Wuxi Shi, China 3 1%
6 Puhua Capital Venture capital firm Hangzhou, China 3 1% 1 Yuce Biotechnology
7 China Life Private Equity Investment Private equity firm Beijing, China 2 0% 1 Weikaier Pharmaceutical Technology
8 Ming Bioventures Venture capital firm Suzhou, China 2 0% 1 Kossel Medical
9 Fortune Venture Capital Venture capital firm Shenzhen, China 2 0% 1 Kossel Medical
10 Northern Light Venture Capital Venture capital firm Beijing, China 2 0% 1 HemaCell
11 Sinovation Ventures Venture capital firm Beijing, China 2 0%
12 Shanghai Biomedical Industrial Equity Investment Fund Venture capital firm Huangpu, China 2 0% 2 Haimai Medical, AccuPulse
13 Zhengxuan Investment Venture capital firm Shenzhen, China 2 0% 1 Yuce Biotechnology
14 Taiyu Investment Venture capital firm Beijing, China 2 0% 1 Tingsheng Technology
15 EFung Capital Private equity firm Shenzhen, China 2 0%

Table 3. Health care startups in Jiangsu, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 195 46% $3.7B
Software 28 7% $145.6M
Hardware 23 5% $142.0M
Artificial intelligence 15 4% $32.6M
Commerce 6 1% $99.1M
Fintech 2 0% $2.0M
Education 1 0% $455K

Table 4. Health care startups in Jiangsu, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Seed 126 30% $1.4M
Series A 139 33% $13.4M
Series B 85 20% $18.0M
Series C 52 12% $26.1M
Series D+ 19 5% $34.6M

Table 5. Health care startups in Jiangsu, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Suzhou 214 51%
Nanjing 119 28%
Wuxi Shi 18 4%
Taizhou 12 3%
Changsha 10 2%
Nantong 8 2%
Zhangjiagang 6 1%
Suzhou Shi 4 1%
Jintan 4 1%
Jiangning 3 1%
Jiangyin 3 1%
Lianyungang 3 1%

Table 6. Health care startups in Jiangsu, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 6 8% $30.0M
September 2026 3 4% $59.5M
August 2026 5 6% $81.9M
July 2026 3 4% $59.1M
June 2026 4 5% $58.6M
May 2026 6 8% $119.4M
April 2026 1 1% $29.3M
March 2026 10 13% $78.2M
February 2026 2 3% $50.6M
January 2026 17 22% $101.4M
December 2025 16 20% $190.9M
November 2025 6 8% $22.5M

Table 7. Health care startups in Jiangsu, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 57 14% $668.0M
2025 78 19% $617.5M
2024 55 13% $339.7M
2023 56 13% $595.5M
2022 45 11% $756.1M
2021 26 6% $1.3B

Table 8. Health care startups in Jiangsu, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 36 9%
2020 to 2022 106 26%
2015 to 2019 155 38%
2010 to 2014 80 19%
Before 2010 35 8%

Table 9. Health care startups in Jiangsu, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 31 10%
11 to 50 117 37%
51 to 100 82 26%
101 to 250 45 14%
251 to 500 21 7%
501 to 1,000 15 5%
1,001 to 5,000 6 2%

Table 10. Health care startups in Jiangsu, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Jiangsu, China are on the list?
421, in the file dated 16 November 2026. 79 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 421 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups in Jiangsu, China: 421 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care startups in Jiangsu, China by funding stage

Other sectors in Jiangsu

Health care startups elsewhere

Cite: FundingWatcher, 421 funded health care companies in Jiangsu, China, 16 November 2026. https://fundingwatcher.com/startups/health-care/jiangsu-china/